Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pathogenesis of Breast Cancer Metastasis to Brain: A Comprehensive Approach to the Signaling Network Publisher Pubmed



Tayyeb B1 ; Parvin M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Molecular Neurobiology Published:2016


Abstract

There is a general consensus that breast cancer is a rising trend disease in the world. It is one of the most common cancer types and is the leading cause of death among women’s cancers. There are several reasons for this high rate of mortality including metastasis which is responsible for about 90 % of cancer-related mortality. Therefore, recognition and understanding of metastatic process is important, and by considering the key role of pathophysiological route in metastasis as a multistep cascade of “invasion–metastasis,” it might modify and improve our insight toward this complex phenomenon. Moreover, it can provide novel approaches for designing advanced targeted therapies. The present work aimed to review the published papers regarding molecular basis of metastatic process of breast cancer to brain metastasis, especially related genes and signaling network. Furthermore, the use of molecular aspects of metastatic breast cancer to brain was discussed in horizon of future treatment of breast cancer. © 2014, Springer Science+Business Media New York.
Other Related Docs
11. Personalized Medicine in Breast Cancer: Pharmacogenomics Approaches, Pharmacogenomics and Personalized Medicine (2019)
18. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
19. Bone Metastasis Prognostic Factors in Breast Cancer, Breast Cancer: Basic and Clinical Research (2019)
20. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
26. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)